{"id":9482,"date":"2020-11-17T09:21:14","date_gmt":"2020-11-17T14:21:14","guid":{"rendered":"https:\/\/www.silverlaw.com\/blog\/?p=9482"},"modified":"2020-11-17T09:21:14","modified_gmt":"2020-11-17T14:21:14","slug":"class-action-lawsuit-filed-for-neovasc-inc-nvcn-investors","status":"publish","type":"post","link":"https:\/\/www.silverlaw.com\/blog\/class-action-lawsuit-filed-for-neovasc-inc-nvcn-investors\/","title":{"rendered":"Class Action Lawsuit Filed For Neovasc Inc. (NVCN) Investors"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-9483 size-full\" src=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2020\/11\/Neovasc.jpg\" alt=\"A class action lawsuit has been filed against Neovasc Inc. (NVCN), a Canadian biotech company, regarding potential violations of federal securities laws.  If you have losses from investing in Neovasc Inc. (NVCN) during the class period between November 1, 2019 and October 27, 2020, contact Silver Law Group for a no-cost consultation at (800) 975-4345 or by email at ssilver@silverlaw.com.  The deadline to apply to be lead plaintiff is January 5, 2021. A class has not been certified in this case. You are not represented by an attorney until certification occurs.  Neovasc Reducer \u00a0  Neovasc Inc. (NVCN) is a specialty medical device company that creates cardiovascular devices for the domestic and international market. Neovasc\u2019s products include the Neovasc Reducer, which is under review by the U.S. Food and Drug Administration (FDA) for treatment of patients with refractory angina pectoris.\" width=\"300\" height=\"200\" srcset=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2020\/11\/Neovasc.jpg 300w, https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2020\/11\/Neovasc-180x120.jpg 180w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/>A class action lawsuit has been filed against Neovasc Inc. (NVCN), a Canadian biotech company, regarding potential violations of federal securities laws.<\/p>\n<p><strong>If you have losses from investing in <\/strong><strong>Neovasc Inc. (NVCN) during the class period between November 1, 2019 and October 27, 2020, contact Silver Law Group for a no-cost consultation at (800) 975-4345 or by email at <\/strong><a href=\"mailto:ssilver@silverlaw.com\" target=\"_blank\"><strong>ssilver@silverlaw.com<\/strong><\/a><strong>. <\/strong> <a href=\"https:\/\/www.silverlaw.com\/blog\/class-action-lawsuit-filed-for-neovasc-inc-nvcn-investors\/#more-9482\" class=\"more-link\">Continue reading \u203a<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A class action lawsuit has been filed against Neovasc Inc. (NVCN), a Canadian biotech company, regarding potential violations of federal securities laws. If you have losses from investing in Neovasc Inc. (NVCN) during the class period between November 1, 2019 and October 27, 2020, contact Silver Law Group for a no-cost consultation at (800) 975-4345 [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[602,1646],"tags":[],"class_list":["post-9482","post","type-post","status-publish","format-standard","hentry","category-class-action","category-securities-fraud"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Class Action Lawsuit Filed For Neovasc Inc. (NVCN) Investors<\/title>\n<meta name=\"description\" content=\"A class action lawsuit has been filed against Neovasc Inc. (NVCN), a Canadian biotech company, regarding potential violations of federal securities laws.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.silverlaw.com\/blog\/class-action-lawsuit-filed-for-neovasc-inc-nvcn-investors\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Class Action Lawsuit Filed For Neovasc Inc. (NVCN) Investors\" \/>\n<meta name=\"twitter:description\" content=\"A class action lawsuit has been filed against Neovasc Inc. (NVCN), a Canadian biotech company, regarding potential violations of federal securities laws.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2020\/11\/Neovasc.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Silver Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Class Action Lawsuit Filed For Neovasc Inc. (NVCN) Investors","description":"A class action lawsuit has been filed against Neovasc Inc. (NVCN), a Canadian biotech company, regarding potential violations of federal securities laws.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.silverlaw.com\/blog\/class-action-lawsuit-filed-for-neovasc-inc-nvcn-investors\/","twitter_card":"summary_large_image","twitter_title":"Class Action Lawsuit Filed For Neovasc Inc. (NVCN) Investors","twitter_description":"A class action lawsuit has been filed against Neovasc Inc. (NVCN), a Canadian biotech company, regarding potential violations of federal securities laws.","twitter_image":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2020\/11\/Neovasc.jpg","twitter_misc":{"Written by":"Silver Law Group","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.silverlaw.com\/blog\/class-action-lawsuit-filed-for-neovasc-inc-nvcn-investors\/#article","isPartOf":{"@id":"https:\/\/www.silverlaw.com\/blog\/class-action-lawsuit-filed-for-neovasc-inc-nvcn-investors\/"},"author":{"name":"Silver Law Group","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752"},"headline":"Class Action Lawsuit Filed For Neovasc Inc. (NVCN) Investors","datePublished":"2020-11-17T14:21:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.silverlaw.com\/blog\/class-action-lawsuit-filed-for-neovasc-inc-nvcn-investors\/"},"wordCount":483,"image":{"@id":"https:\/\/www.silverlaw.com\/blog\/class-action-lawsuit-filed-for-neovasc-inc-nvcn-investors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2020\/11\/Neovasc.jpg","articleSection":["Class Action","Securities Fraud"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.silverlaw.com\/blog\/class-action-lawsuit-filed-for-neovasc-inc-nvcn-investors\/","url":"https:\/\/www.silverlaw.com\/blog\/class-action-lawsuit-filed-for-neovasc-inc-nvcn-investors\/","name":"Class Action Lawsuit Filed For Neovasc Inc. (NVCN) Investors","isPartOf":{"@id":"https:\/\/www.silverlaw.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.silverlaw.com\/blog\/class-action-lawsuit-filed-for-neovasc-inc-nvcn-investors\/#primaryimage"},"image":{"@id":"https:\/\/www.silverlaw.com\/blog\/class-action-lawsuit-filed-for-neovasc-inc-nvcn-investors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2020\/11\/Neovasc.jpg","datePublished":"2020-11-17T14:21:14+00:00","author":{"@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752"},"description":"A class action lawsuit has been filed against Neovasc Inc. (NVCN), a Canadian biotech company, regarding potential violations of federal securities laws.","breadcrumb":{"@id":"https:\/\/www.silverlaw.com\/blog\/class-action-lawsuit-filed-for-neovasc-inc-nvcn-investors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.silverlaw.com\/blog\/class-action-lawsuit-filed-for-neovasc-inc-nvcn-investors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.silverlaw.com\/blog\/class-action-lawsuit-filed-for-neovasc-inc-nvcn-investors\/#primaryimage","url":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2020\/11\/Neovasc.jpg","contentUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2020\/11\/Neovasc.jpg","width":300,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/www.silverlaw.com\/blog\/class-action-lawsuit-filed-for-neovasc-inc-nvcn-investors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.silverlaw.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Class Action Lawsuit Filed For Neovasc Inc. (NVCN) Investors"}]},{"@type":"WebSite","@id":"https:\/\/www.silverlaw.com\/blog\/#website","url":"https:\/\/www.silverlaw.com\/blog\/","name":"Securities Arbitration Lawyers Blog","description":"Published by Securities Arbitration Lawyers \u2014 Silver Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.silverlaw.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752","name":"Silver Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","caption":"Silver Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/9482","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/comments?post=9482"}],"version-history":[{"count":1,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/9482\/revisions"}],"predecessor-version":[{"id":9484,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/9482\/revisions\/9484"}],"wp:attachment":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/media?parent=9482"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/categories?post=9482"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/tags?post=9482"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}